← Feed

$BSX

2 theses
bullish 100%neutral 0%bearish 0%
Avg return (3m)
—
Win rate (3m)
— (0 resolved)
1d3d1w1m3m6m1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Sep 10, 4:30 PM ET
$BSXr/ValueInvestingStock Analysisbullish
u/Ancient_Bobcat_9150 · 19h ago1 prior · awaiting results

Boston Scientific: Too soon to catch a falling knife?

Boston Scientific trades at a 14x forward P/E—a discount to the historical 20x–25x range for high-moat medtech—while growing organic sales at 7% and adjusted EPS at 15% YoY. Management is competent, actively shareholder-friendly via buybacks, and the company remains well-positioned in mission-critical markets despite near-term cyberattack-driven headwinds.

At post $43.10Now $43.100.0% since postedas of Sep 10, 4:30 PM ET
original post →
$BSXr/ValueInvestingIndustry/Sectorbullish
u/raytoei · 48d ago9 prior · awaiting results

Medical-Device Stocks Are in the Bargain Bin. 6 to Buy - Barron’s

Boston Scientific has been hammered down 50% this year on modest guidance cuts, but at 13x forward earnings and with a 6% cash-flow yield, it represents excellent value. New ablation products and an aggressive buyback program position it for recovery.

Now $43.10as of Sep 10, 4:30 PM ET
original post →

End of results.